Characterization and Genome Analysis of Staphylococcus aureus Podovirus CSA13 and Its Anti-Biofilm Capacity

Staphylococcus aureus is one of the notable human pathogens that can be easily encountered in both dietary and clinical surroundings. Among various countermeasures, bacteriophage therapy is recognized as an alternative method for resolving the issue of antibiotic resistance. In the current study, ba...

Full description

Bibliographic Details
Main Authors: Yoyeon Cha, Jihwan Chun, Bokyung Son, Sangryeol Ryu
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Viruses
Subjects:
Online Access:http://www.mdpi.com/1999-4915/11/1/54
_version_ 1828445807343304704
author Yoyeon Cha
Jihwan Chun
Bokyung Son
Sangryeol Ryu
author_facet Yoyeon Cha
Jihwan Chun
Bokyung Son
Sangryeol Ryu
author_sort Yoyeon Cha
collection DOAJ
description Staphylococcus aureus is one of the notable human pathogens that can be easily encountered in both dietary and clinical surroundings. Among various countermeasures, bacteriophage therapy is recognized as an alternative method for resolving the issue of antibiotic resistance. In the current study, bacteriophage CSA13 was isolated from a chicken, and subsequently, its morphology, physiology, and genomics were characterized. This Podoviridae phage displayed an extended host inhibition effect of up to 23 hours of persistence. Its broad host spectrum included methicillin susceptible S. aureus (MSSA), methicillin resistant S. aureus (MRSA), local S. aureus isolates, as well as non-aureus staphylococci strains. Moreover, phage CSA13 could successfully remove over 78% and 93% of MSSA and MRSA biofilms in an experimental setting, respectively. Genomic analysis revealed a 17,034 bp chromosome containing 18 predicted open reading frames (ORFs) without tRNAs, representing a typical chromosomal structure of the staphylococcal Podoviridae family. The results presented here suggest that phage CSA13 can be applicable as an effective biocontrol agent against S. aureus.
first_indexed 2024-12-10T22:03:10Z
format Article
id doaj.art-4c29600df20447a78e901112beb839f2
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-12-10T22:03:10Z
publishDate 2019-01-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-4c29600df20447a78e901112beb839f22022-12-22T01:31:51ZengMDPI AGViruses1999-49152019-01-011115410.3390/v11010054v11010054Characterization and Genome Analysis of Staphylococcus aureus Podovirus CSA13 and Its Anti-Biofilm CapacityYoyeon Cha0Jihwan Chun1Bokyung Son2Sangryeol Ryu3Department of Food and Animal Biotechnology, Seoul National University, Seoul 08826, KoreaDepartment of Food and Animal Biotechnology, Seoul National University, Seoul 08826, KoreaDepartment of Food and Animal Biotechnology, Seoul National University, Seoul 08826, KoreaDepartment of Food and Animal Biotechnology, Seoul National University, Seoul 08826, KoreaStaphylococcus aureus is one of the notable human pathogens that can be easily encountered in both dietary and clinical surroundings. Among various countermeasures, bacteriophage therapy is recognized as an alternative method for resolving the issue of antibiotic resistance. In the current study, bacteriophage CSA13 was isolated from a chicken, and subsequently, its morphology, physiology, and genomics were characterized. This Podoviridae phage displayed an extended host inhibition effect of up to 23 hours of persistence. Its broad host spectrum included methicillin susceptible S. aureus (MSSA), methicillin resistant S. aureus (MRSA), local S. aureus isolates, as well as non-aureus staphylococci strains. Moreover, phage CSA13 could successfully remove over 78% and 93% of MSSA and MRSA biofilms in an experimental setting, respectively. Genomic analysis revealed a 17,034 bp chromosome containing 18 predicted open reading frames (ORFs) without tRNAs, representing a typical chromosomal structure of the staphylococcal Podoviridae family. The results presented here suggest that phage CSA13 can be applicable as an effective biocontrol agent against S. aureus.http://www.mdpi.com/1999-4915/11/1/54BacteriophageStaphylococcus aureusanti-biofilmgenome analysis
spellingShingle Yoyeon Cha
Jihwan Chun
Bokyung Son
Sangryeol Ryu
Characterization and Genome Analysis of Staphylococcus aureus Podovirus CSA13 and Its Anti-Biofilm Capacity
Viruses
Bacteriophage
Staphylococcus aureus
anti-biofilm
genome analysis
title Characterization and Genome Analysis of Staphylococcus aureus Podovirus CSA13 and Its Anti-Biofilm Capacity
title_full Characterization and Genome Analysis of Staphylococcus aureus Podovirus CSA13 and Its Anti-Biofilm Capacity
title_fullStr Characterization and Genome Analysis of Staphylococcus aureus Podovirus CSA13 and Its Anti-Biofilm Capacity
title_full_unstemmed Characterization and Genome Analysis of Staphylococcus aureus Podovirus CSA13 and Its Anti-Biofilm Capacity
title_short Characterization and Genome Analysis of Staphylococcus aureus Podovirus CSA13 and Its Anti-Biofilm Capacity
title_sort characterization and genome analysis of staphylococcus aureus podovirus csa13 and its anti biofilm capacity
topic Bacteriophage
Staphylococcus aureus
anti-biofilm
genome analysis
url http://www.mdpi.com/1999-4915/11/1/54
work_keys_str_mv AT yoyeoncha characterizationandgenomeanalysisofstaphylococcusaureuspodoviruscsa13anditsantibiofilmcapacity
AT jihwanchun characterizationandgenomeanalysisofstaphylococcusaureuspodoviruscsa13anditsantibiofilmcapacity
AT bokyungson characterizationandgenomeanalysisofstaphylococcusaureuspodoviruscsa13anditsantibiofilmcapacity
AT sangryeolryu characterizationandgenomeanalysisofstaphylococcusaureuspodoviruscsa13anditsantibiofilmcapacity